Background: Instrumental vaginal delivery is a major concern during epidural labour analgesia. In previous studies levobupivacaine 0.1% was associated with increase in instrumental vaginal delivery when compared to 0.1% ropivacaine. Reducing the concentration of levobupivacaine may decrease the incidence of instrumental delivery. Hence, we compared 0.08% levobupivacaine and 0.1% ropivacaine with fentanyl as adjuvant for epidural labour analgesia in terms of mode of delivery.
Introduction
Epidural labour analgesia (EA) is known to be associated with operative delivery, instrumental assisted deliveries and prolonged labour. With the use of minimum local anaesthetic concentration (MLAC) and opioids as additives, many studies had proved that EA is not associated with increased caesarean section (CS) rate 1 but discussions regarding its influence on instrumental vaginal delivery (IVD) 2 and duration of labour 3 still persists thereby affecting the neonatal outcome. 4 Kumar et al 5 found that the incidence of IVD was 32% with 0.1% levobupivacaine and none with ropivacaine. Studies have been done with 0.0625% levobupivacaine for labour analgesia but found that frequent additional rescue drug was required to produce satisfactory analgesia. 6, 7 Hence, we compared the effectiveness of 0.1% ropivacaine and 0.08% levobupivacaine with fentanyl as adjuvant for epidural labour analgesia in terms of mode of delivery. Methodology Following approval from the institutional ethical committee, this prospective randomized doubleblind study was conducted at a tertiary medical college hospital. All pregnant nulliparous women admitted to the Department of Obstetrics and Gynaecology for confinement and who requested for labour analgesia from December 2015 to May 2017 were invited to participate in the study. Detailed education about epidural labour analgesia and explanation about the study protocol was given to the parturients.
Seventy primigravidae, ASA I and II, age between 18yrs to 32yrs with singleton pregnancy with vertex presentation were included in the study. All those parturients who were high risk pregnancies, CPD, foetal anomaly, and any contraindications for neuraxial block (local anaesthetic toxicity, injection site infection, coagulopathy and spine abnormalities) were excluded from the study. Parturients who were willing to participate in the study were selected by convenient sampling and they were randomized to one of the two groups levobupivacaine (A) and ropivacaine (B) by sealed envelope technique. Written informed consent was obtained from all the participants.
During early stage of labour, acid aspiration prophylaxis was given intravenously and the parturient was shifted to operating room and connected to standard monitors (pulse-oximetry, noninvasive blood pressure, ECG) and the base line values were noted. Preloading was done with 500ml of Ringers' lactate solution using 18G peripheral venous cannula. Following strict aseptic precautions, epidural space was identified in left lateral position at L2-L3 or L3-L4 with an 18G Touhy needle (Perifix, B-Braun Epidural catheter kit) using loss of resistance to air technique and 18G multi-orifice epidural catheter was threaded cephalad and fixed with 4-5cm of the catheter within the space. After confirming negative aspiration to blood or CSF, epidural test dose was given with 3ml of 1.5% lignocaine with 15μg adrenaline. Ruling out intravascular and intrathecal placement, the catheter was secured and the parturient was shifted back to labour ward. Pain was assessed by using VAS of 10cm from 0-10 and initial VAS score was assessed.
Study by Kumar et al 7 showed that the incidence of instrumental delivery with 0.1% levobupivacaine was 32% and nil with 0.1% ropivacaine. We hypothesised that by reducing the concentration of levobupivacaine to 0.08% (equipotent dose), there will be a reduction in instrumental delivery by 80%. To compare the two groups, with alpha error of 0.05 and beta error of 80% the sample size required was 31 in each group. We took a sample size of 35 to allow for withdrawals from study during labour.
Patients were divided into two groups of 35 each. Patients in group-A (n=35) received 12ml of 0.08% levobupivacaine with 2μg/ml fentanyl and group-B (n=35) received 12ml of 0.1% ropivacaine with 2μg/ml fentanyl as an adjuvant to their study solution. The study solutions were prepared aseptically by an anaesthetist who was not directly involved in this study. When the parturient went in to an active stage of labour (cervical dilation > or = 3cm) standard monitoring was started and the epidural analgesia was initiated during contraction free period in supine position over a period of 2-3min.The time of the injection of the initial dose was kept as time zero and assessments were scheduled accordingly. The adequacy of analgesia was assessed at every 5min intervals and analgesia was considered adequate if the VAS reduced to < 3. The onset of analgesia was defined as time from the first dose to the time of achieving VAS < 3. If analgesia was inadequate in 30min after the initial dose, an additional 12ml of the same drug solution was injected and VAS score was assessed. If analgesia is further inadequate, alternative mode of analgesia was provided after consulting with attending anaesthetist and the case was excluded from the study. Fifteen minutes after adequate analgesia was achieved, quality of analgesia was assessed by verbal scoring system (0-no pain, 1-aware of contractions but not painful, 2-aware of pressure but tolerable discomfort, 3-distressing pain or pressure) and motor blockade was assessed using a Modified Bromage Score. All parturients with motor blockade score-0 was given a supervised trial walk to assess their ability to ambulate and were encouraged to ambulate until obstetrician augmented the labour. Whenever parturient complained of pain (VAS >3) epidural top-up was given with 12ml of the same study solution. During the second stage of labour, top ups were given in sitting posture if required. Haemodynamic parameters of mother (oxygen saturation, pulse rate, blood pressure), and foetal heart rate (FHR) was monitored at 10min intervals throughout the study. Pruritus, nausea, sedation was assessed at 30min intervals.
The mode of delivery, and the indication for instrumental delivery/caesarian section, was noted. Neonatal assessment was done with Apgar score of the baby at the 1 st and 5 th minutes. One hour after the delivery of the baby, the mother was enquired about their satisfaction regarding labour analgesia on a 4-point scale. 3-excellent pain relief, 2-good pain relief, 1-fair pain relief and 0-poor pain relief.
During the study period hypotension was defined as systolic blood pressure of <90 mmHg and was treated with an intravenous bolus of 6mg mephenteramine. Heart rate < 60bpm, was treated with an i.v. bolus dose of 0.6mg atropine sulfate. If parturient went for cesarean section, epidural anaesthesia was achieved with 12ml of 2% lignocaine with adrenaline. In levobupivacaine group 4 parturients and in ropivacaine group 13 underwent caesarean section which was statistically significant (p=0.012**) Onset of analgesia (p=0.37), duration of epidural analgesia (p=0.66), duration of labour (p=0.747) were comparable and statistically not significant between the two groups. In either group no parturients had distressing pressure or pain during uterine contractions. Quality of analgesia was comparable between the levobupivacaine and ropivacaine groups. The maternal heart rate was stable in both levobupivacaine and ropivacaine groups throughout the study period. Only 5% of parturients had sinus tachycardia (rise of more than 20% from base line) and was attributed to the use of intravenous valethamate bromide for augmenting the cervical dilatation. In both levobupivacaine and ropivacaine group there was no significant change in blood pressure (mean arterial pressure). In both the groups all new borns had good Apgar score of more than seven at one and nine at five minutes.
All data was entered into a Data Collection Proforma Sheet (MS Excel 2011

Discu ssion
Labour analgesia is still an unmet right for parturients in India because of lack of parturient awareness and myths and controversies among the providers such as increased risk of instrumentation 8 and operative delivery. 9 Previous studies have shown that the rate of instrumental vaginal delivery depends on several confounding factors such as the dose and concentration of the epidural solution used, 10 the degree of analgesia during second stage, 11 and obstetric factors. Reduction of serum oxytocin levels can result in a weakening of uterine activity. 12 Maternal efforts at expulsion can also be impaired, causing foetal malposition during descent. 13 Previously, the association of neonatal morbidity and mortality with longer labour (second stage longer than two hours) had justified expediting delivery, leading to increased rates of instrumental delivery. 14 Increased rates of instrumental vaginal delivery are important as it increases the risk of maternal perineal trauma 15 and in cases of difficult mid forceps delivery increases the risk of adverse neonatal outcomes. 16 As such, minimizing the risk of instrumental vaginal delivery while maximizing patient comfort is an art and a science, requiring diligence by the anaesthesia provider to the individual needs of each parturient.
Purdie et al 17 compared 0.1% levobupivacaine and 0.1% ropivacaine with fentanyl by PCEA for labour analgesia and found 50% instrumental vaginal delivery with ropivacaine and 32% with levobupivacaine. Kumar et al 5 compared the same drug with same concentration by intermittent bolus technique and found similar 32% instrumental vaginal delivery with levobupivacaine but nil in ropivacaine group and they attributed the cause to be pelvic floor muscle laxity caused by more potent levobupivacaine than ropivacaine in equal concentrations. There is no literature available regarding 0.08% levobupivacaine with fentanyl for labour analgesia. Hence, we reduced the concentration of levobupivacaine and studied its effects on the incidence of instrumental vaginal delivery (IVD) in comparison to 0.1% ropivacaine.
In our study we found that the incidence of IVD (low outlet forceps) was 6.45% with levobupivacaine group and 4.54% with ropivacaine group and was not statistically significant. On analyzing the indications for instrumentation, they were face to pubis delivery in two parturients in levobupivacaine group and poor maternal effort in one parturient in ropivacaine group. Lieberman et al 18 in his prospective cohort study found that epidural analgesia was associated with significantly higher incidence of occcipito posterior fetus position at delivery. A meta-analysis done by Brancato et al 19 found that delayed pushing effort by the mother encouraged passive descent of the foetal head during II nd stage of labour and had significant positive effects on increased incidence of the spontaneous vaginal deliveries, and decreased instrument-assisted vaginal deliveries associated with shortened pushing time with EA and the same was suggested by Miller as early as 1997. With increasing use of continuous electronic foetal monitoring, a longer but more comfortable labour may cause little harm to the neonate. Updated Cochrane database 2017 20 and ACOG guidelines (2017) on obstetric analgesia also recommends delaying the pushing of parturient till full dilatation of cervix to enhance the rotation of foetal head.
In our study we observed that the incidence of CS was significantly higher in ropivacaine group (p=0.012**). The indications of the CS were meconium stained liquor, foetal distress, cord prolapse, arrest of dilatation and deep transverse arrest. The time interval between last epidural top-up and foetal distress was more than 50mins and with a stable blood pressure. However earlier studies by Purdie et al 17 and Kumar et al 7 showed no difference in incidence of CS rates with 0.1% of both levobupivacaine and ropivacaine with fentanyl.
In our study, we found that the mean onset of analgesia and the mean duration of analgesia was comparable between the two drugs but Kumar et al 5 found a statistically significant difference in the mean onset and mean duration of analgesia with 0.1% levobupivacaine and ropivacaine but did not find any clinical significance.
Parturients did not have motor blockade and they had stable haemodynamics in both groups and comparable duration of labour. Analysis of quality of analgesia during peak uterine contraction was a unique factor of the study and74% parturients categorised it as excellent (parturients did not perceive the discomfort produced by uterine contraction). All newborns had good Apgar scores. In our study the maternal satisfaction score was done one hour after the delivery of the baby and we observed that >80% of mothers in either of the groups (levobupivacaine and ropivacaine) had excellent satisfaction score for pain relief which was similar to Purdie et al. 17 
Conclusion
We conclude that 12ml of intermittent epidural boluses of 0.08% levobupivacaine and 0.1% ropivacaine with 2mcg/ml fentanyl provide equal and effective analgesia during labour with reduced and comparable maternal outcome in terms of instrumental vaginal delivery.
Strength of the study Robust methodology with randomisation and double blinding
Limitations
Obstetricians with varied experiences managed our parturients and decision making regarding mode of delivery was subjective to their skill and possible effect of these drugs on each stage of labour was not analysed.
Suggestions for future research
For further studies on labour analgesia, we would suggest that studies should be directed to assess the parturient anxiety level and knowledge about labour process before institution of labour analgesia and the obstetrician working experience and attitude towards labour analgesia and its effect on labour outcome.
